<--- Back to Details
First PageDocument Content
Organochlorides / Bristol-Myers Squibb / Clopidogrel / Prodrugs / Sanofi / Bioequivalence / Generic drug / Abbreviated New Drug Application / Food and Drug Administration / Pharmacology / Pharmaceutical sciences / Chemistry
Date: 2012-07-03 06:53:17
Organochlorides
Bristol-Myers Squibb
Clopidogrel
Prodrugs
Sanofi
Bioequivalence
Generic drug
Abbreviated New Drug Application
Food and Drug Administration
Pharmacology
Pharmaceutical sciences
Chemistry

PERSPECTIVE Generics and Biosimilars Initiative Journal

Add to Reading List

Source URL: gabi-journal.net

Download Document from Source Website

File Size: 147,94 KB

Share Document on Facebook

Similar Documents

A Day in Life at BMS Welcome to A Day in Life at BMS where you will meet leaders from our R&D organization and learn more about research and development at Bristol-Myers Squibb, as well as network with our scientists. To

DocID: 1vrK6 - View Document

NoIN THE Supreme Court of the United States BRISTOL-MYERS SQUIBB COMPANY, PETITIONER,

DocID: 1tuCc - View Document

Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty)

DocID: 1tut4 - View Document

September 2003 USA Bristol-Myers Squibb Medical Imaging

DocID: 1sKnx - View Document

May 2003 Bristol-Myers Squibb Medical Imaging 331 Treble Cove Road N. Billerica, Massachusetts 01862

DocID: 1sC8T - View Document